What's Happening With RXRX Stock? - Forbes
Yesterday • Google News
Recursion Pharmaceuticals Inc (RXRX)
US$ 5.841.92%
Price Chart
Key Statistics
Market Cap
$ 2.18B
P/E Ratio
0.00
Revenue (TTM)
$ 59.79M
Volume
13.44M
52W High
$ 12.36
52W Low
$ 3.79
Dividend Yield
0.00%
Beta
0.83
Technicals
50-Day MA
4.8717
200-Day MA
6.2997
52 Week High
12.36
52 Week Low
3.79
About RXRX
Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology and chemistry by integrating technological innovations across biology, chemistry, au.
Employees
800
Headquarters
Salt Lake City, UT
CEO
Dr. Christopher C. Gibson Ph.D.
Latest News
Recursion Pharmaceuticals (RXRX) Drops on Profit-Taking - Yahoo Finance
19 hours ago • Google News
Will RXRX's Shift in Pipeline Focus Help Restore Investor Faith? - MSN
12 hours ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg